|
Sandy, I'm not SURE about this, but the only trial I saw still open is for brain mets progression: Tykerb+Xeloda.
Also, the dosages of Xeloda used in trials were on the low side, if I recall correctly. A GOOD thing. Still worked effectively.
My personal concerns now are this er receptor being turned ON by the Tykerb... it seems it's always something. Have waited a year (?) for the drug, now this big question mark...
I do appreciate your report on the timing of availability. Thanks for that.
hugs,
pattyz
|
Threaded Mode